US Stock MarketDetailed Quotes
MBX MBX Biosciences
- 18.500
- +1.990+12.05%
Close Nov 22 16:00 ET
- 18.500
- 0.0000.00%
Post 20:01 ET
618.22MMarket Cap-11191P/E (TTM)
19.000High16.750Low127.31KVolume16.750Open16.510Pre Close2.25MTurnover1.25%Turnover RatioLossP/E (Static)33.42MShares27.50052wk High2.28P/B188.70MFloat Cap15.31052wk Low--Dividend TTM10.20MShs Float27.500Historical High--Div YieldTTM13.63%Amplitude15.310Historical Low17.662Avg Price1Lot Size
About MBX Biosciences Company
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.
Company Profile
SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com
Company Executives
- Name
- Position
- Salary
- Peter Kent Hawryluk
- President, Chief Executive Officer and Director
- 4.86M
- Dr. Salomon Azoulay, M.D.
- Chief Medical Officer
- --
- Richard B. Bartram
- Chief Financial Officer and Principal Accounting Officer
- 1.05M
- Dr. Ora H. Pescovitz, M.D.
- Independent Director
- --
- Patrick J. Heron
- Independent Director
- --
- James M. Cornelius
- Independent Director
- --
- Edward T. Mathers
- Independent Director
- --
- Dr. Tiba Aynechi, PhD
- Independent Director
- --
- Dr. Steven Ryder, M.D.
- Independent Director
- --
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
